For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

Highly pathogenic avian influenza H5N1 is estimated to have killed at least about 52,000 seals and sea lions across South America, based on published scientific tallies of the 2023 outbreak and its ...

The virus is the human polyomavirus 2, commonly called either the JC virus or John Cunningham virus, named after the poor ...

Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a ...

Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and ...

Infectious diseases remain a leading cause of morbidity and mortality worldwide, posing significant challenges to healthcare systems. Beyond the direct ...

B virus infection causes rapidly progressive meningoencephalitis and severe ocular involvement, including necrotizing chorioretinitis and uveitis.

A 'superfood' commonly found in restaurants and grocery stores may be able to prevent an infection with a common, and ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Drugs and different treatments approved by the U.S. Food and Drug Administration (FDA) for a specific disease can be repurposed for other pathologies. The | Immunology ...

TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...